MPHETAS 500MG 10S

Mphetas is generally prescribed alongside other immunosuppressant medicines as part of a transplant treatment plan. It requires careful medical supervision to monitor treatment effectiveness and potential side effects.

Key Features and Benefits:

• Prevention of organ rejection: Helps reduce the risk of the immune system rejecting a transplanted organ.

• Immune system suppression: Reduces the activity of specific immune cells involved in transplant rejection.

• Combination treatment: Used with other prescribed immunosuppressants as directed by a transplant specialist.

• Convenient packaging: Supplied in a pack of 10 tablets.

Important Safety Information: Mphetas increases the risk of infections and may cause serious adverse effects. Mycophenolate mofetil can cause miscarriage and severe birth defects, so strict pregnancy-prevention precautions are essential for patients who could become pregnant. Regular medical monitoring is required. Use only under the supervision of a qualified specialist, and do not stop treatment without medical advice.